Patent ID: 8716492

Claim:
A compound according to Formula (II): or its stereoisomers, tautomers, pharmaceutically acceptable salts thereof, wherein: A is substituted with 0-1 R 1 and 0-2 R 2 and selected from: thienyl, indazolyl, benzisoxazolyl, isoquinolinyl, 5,6,7,8-tetrahydroisoquinolinyl, 1,2,3,4-tetrahydroisoquinolinyl, quinazolinyl, 1H-quinazolin-4-onyl, 2H-isoquinolin-1-onyl, 3H-quinazolin-4-onyl, 3,4-dihydro-2H-isoquinolin-1-onyl, and L is —C(O)NH—, —NHC(O)—, —CH 2 C(O)NH—, or S(O) 2 NH—; R 1 is, independently at each occurrence, F, Cl, Me, Et, —NH 2 , —C(═NH)NH 2 , —C(O)NH 2 , —CH 2 NH 2 , —CH 2 NHCO 2 Bn, —CH 2 NHCO 2 (t-Bu), —CH(Me)NH 2 , —CMe 2 NH 2 , —NHEt, —NHCO 2 (t-Bu), —NHCO 2 Bn, or —SO 2 NH 2 ; R 2 is, independently at each occurrence, H, ═O, F, Cl, Br, I, OCF 3 , CF 3 , CHF 2 , CN, NO 2 , —C(O)Ph or —C(O)OBn; R 3 is phenyl substituted with 0-2 R 3a , or a 5- to 10-membered heterocycle comprising: carbon atoms and 1-2 heteroatoms selected from N, O, and S(O) p , wherein said heterocycle is substituted with 0-2 R 3a ; R 3a is, independently at each occurrence, ═O, F, Cl, Br, I, OCF 3 , CF 3 , NO 2 , CN, OH, O(C 1-6 alkyl), NH 2 , NH(C 1-6 alkyl), N(C 1-6 alkyl) 2 , —O(═NH)NH 2 , —CO 2 H, —CO 2 C 1-6 alkyl, —C(O)NH 2 , —O(O)NH(C 1-6 alkyl), or —O(O)N(C 1-6 alkyl) 2 ; R 4 is H, F, Cl, Br, OMe, NH 2 , CF 3 , CO 2 H, CO 2 Me, CO 2 Et, or C 1-6 alkyl; R 11 is —(CH 2 ) r -phenyl substituted with 0-2 R 11b ; R 11b is, independently at each occurrence, H, F, Cl, Br, CF 3 , OMe, OEt, O(i-Pr), OCF 3 , OCHF 2 , CN, OPh, OBn, NO 2 , —NH 2 , or —C(O)N(C 1-6 alkyl) 2 ; p, at each occurrence, is selected from 0, 1, and 2; r, at each occurrence, is selected from 0, 1, 2, 3, and 4.